Showing results (871-880 of 9,668) with videos related to
Sort By:
Pageof 967
Leukemia|December 1, 2016
Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myelomaS Mithraprabhu, T Khong, M Ramachandran, et al.Leukemia|December 3, 2016
RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib responseI J F Hofman, M van Duin, E De Bruyne, et al.Leukemia|May 3, 2014
Complement deficiencies limit CD20 monoclonal antibody treatment efficacy in CLLO Middleton, E Cosimo, E Dobbin, et al.Leukemia|December 7, 2016
EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemiaS Charmsaz, F Al-Ejeh, T M Yeadon, et al.Leukemia|October 11, 2016
Isocitrate dehydrogenase mutations in myeloid malignanciesB C Medeiros, A T Fathi, C D DiNardo, et al.Leukemia|October 14, 2016
Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrencesE Waanders, B Scheijen, M C J Jongmans, et al.Leukemia|October 1, 1989
Multiple sclerosis in mothers of children with acute lymphoblastic leukemiaJ D Buckley, G S Gilchrist, K Ruccione, et al.Leukemia|May 1, 1988
Immunophenotype of leukemic blasts with small peroxidase-positive granules detected by electron microscopyW Vainchenker, J L Villeval, A Tabilio, et al.Leukemia|April 4, 2017
A novel AHI-1-BCR-ABL-DNM2 complex regulates leukemic properties of primitive CML cells through enhanced cellular endocytosis and ROS-mediated autophagyX Liu, K Rothe, R Yen, et al.Leukemia|April 5, 2017
Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trialN J Bahlis, A Corso, L-O Mugge, et al.Pageof 967